The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials

The devastating Ebola virus (EBOV) epidemic in West Africa in 2013–2016 accelerated the progress of several vaccines and antivirals through clinical trials, including the replication-competent vesicular stomatitis virus-based vaccine expressing the EBOV glycoprotein (VSV-EBOV). Extensive preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Suder, Ellen, Furuyama, Wakako, Feldmann, Heinz, Marzi, Andrea, de Wit, Emmie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183239/
https://www.ncbi.nlm.nih.gov/pubmed/29757706
http://dx.doi.org/10.1080/21645515.2018.1473698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183239/
https://www.ncbi.nlm.nih.gov/pubmed/29757706
http://dx.doi.org/10.1080/21645515.2018.1473698

Ejemplares similares